1. Home
  2. HUN vs MLTX Comparison

HUN vs MLTX Comparison

Compare HUN & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huntsman Corporation

HUN

Huntsman Corporation

N/A

Current Price

$8.16

Market Cap

1.7B

Sector

Industrials

ML Signal

N/A

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

N/A

Current Price

$10.75

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HUN
MLTX
Founded
1970
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
HUN
MLTX
Price
$8.16
$10.75
Analyst Decision
Hold
Buy
Analyst Count
14
15
Target Price
$10.62
★ $28.54
AVG Volume (30 Days)
★ 2.5M
1.9M
Earning Date
11-02-2026
11-04-2026
Dividend Yield
★ 4.12%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $5,683,000,000.00
N/A
Revenue This Year
$8.52
N/A
Revenue Next Year
$2.22
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$7.30
$8.80
52 Week High
$16.09
$23.29

Technical Indicators

Market Signals
Indicator
HUN
MLTX
Relative Strength Index (RSI) 32.39 29.80
Support Level $8.10 N/A
Resistance Level $9.99 $19.24
Average True Range (ATR) 0.31 0.66
MACD 0.01 0.01
Stochastic Oscillator 6.36 20.60

Price Performance

Historical Comparison
HUN
MLTX

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. The product portfolio of the company comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, and others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. The company derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: